Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Friis Bach

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|May 1, 2010
[How to achieve an easier way to clinical research?]Karin Friis Bach
Ugeskrift for Laeger|January 12, 2011
[Empty cardboard boxes and lobbyism]Karin Friis Bach
Ugeskrift for Laeger|March 18, 2014
[Simplification of procedures for clinical drug trials in the EU is coming up]Karin Friis Bach, Annette Jørgensen
Ugeskrift for Laeger|January 6, 2006
[What is necessary to archive when one writes a case report?]Nina H Bjarnason, Karin Friis Bach
Basic & Clinical Pharmacology & Toxicology|January 30, 2004
Good clinical practice is now obligatory in academic clinical drug research in the European UnionAnnette Jørgensen, Karin Friis Bach, Karen Friis
Ugeskrift for Laeger|June 4, 2004
[Is good clinical practice a problem?]Karin Friis Bach, Karen Friis, Annette Jørgensen
Ugeskrift for Laeger|June 4, 2004
[New regulations on drug research]Karin Friis Bach, Karen Friis, Annette Jørgensen
Ugeskrift for Laeger|September 10, 2002
[Osteoarthritis]Janne Unkerskov, Dorte Glintborg, Karin Friis Bach, et al.
Plos One|May 10, 2017
Barriers towards the publication of academic drug trials. Follow-up of trials approved by the Danish Medicines AgencyLouise Berendt, Lene Grejs Petersen, Karin Friis Bach, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
A Paradigm Shift Towards Patient Involvement in Medicines Development and Regulatory Science: Workshop Proceedings and CommentaryGitte Borup, Karin Friis Bach, Merete Schmiegelow, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|May 1, 2010
[How to achieve an easier way to clinical research?]Karin Friis Bach
Ugeskrift for Laeger|January 12, 2011
[Empty cardboard boxes and lobbyism]Karin Friis Bach
Ugeskrift for Laeger|March 18, 2014
[Simplification of procedures for clinical drug trials in the EU is coming up]Karin Friis Bach, Annette Jørgensen
Ugeskrift for Laeger|January 6, 2006
[What is necessary to archive when one writes a case report?]Nina H Bjarnason, Karin Friis Bach
Basic & Clinical Pharmacology & Toxicology|January 30, 2004
Good clinical practice is now obligatory in academic clinical drug research in the European UnionAnnette Jørgensen, Karin Friis Bach, Karen Friis
Ugeskrift for Laeger|June 4, 2004
[Is good clinical practice a problem?]Karin Friis Bach, Karen Friis, Annette Jørgensen
Ugeskrift for Laeger|June 4, 2004
[New regulations on drug research]Karin Friis Bach, Karen Friis, Annette Jørgensen
Ugeskrift for Laeger|September 10, 2002
[Osteoarthritis]Janne Unkerskov, Dorte Glintborg, Karin Friis Bach, et al.
Plos One|May 10, 2017
Barriers towards the publication of academic drug trials. Follow-up of trials approved by the Danish Medicines AgencyLouise Berendt, Lene Grejs Petersen, Karin Friis Bach, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
A Paradigm Shift Towards Patient Involvement in Medicines Development and Regulatory Science: Workshop Proceedings and CommentaryGitte Borup, Karin Friis Bach, Merete Schmiegelow, et al.
Pageof 2